Prisoners have significantly greater levels of drug use than the general population, which is
related to many adverse outcomes both during and post‐imprisonment. Reducing the …

This paper presents a systematic literature review on the detection of new psychoactive
substances (NPS) in prison settings. It includes the most frequently reported NPS classes …

Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive
substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid …

In recent years, several nations have implemented various measures to control the surge of
new synthetic cannabinoid receptor agonists (SCRAs) entering the recreational drug market …

Early warning systems detect new psychoactive substances (NPS), while dedicated
monitoring programs and routine drug and toxicology testing identify fluctuations in …

The synthetic cannabinoid receptor agonist (SCRA) market is transnational, and the
availability of individual SCRAs changes regularly in response to national and international …

Synthetic cannabinoid receptor agonists (SCRAs) remain a major public health concern,
with their use implicated in intoxications and drug-related deaths worldwide. Increasing our …

The article presents a systematic literature review on the use and the psychiatric implications
of over-the-counter drugs (OTC), prescription-only-medications (POM), and new …

In the past years, new psychoactive substances (NPS) started circulating in prisons, leading
to health risks and challenges for the criminal justice system. Seizures of papers and cards …

ADB-FUBINACA and AMB-FUBINACA are two synthetic indazole-derived cannabinoid
receptor agonists, up to 140-and 85-fold more potent, respectively, than trans-∆ 9 …